Actively participate in international high-quality clinical trials for improving the research level of colorectal surgery in China
10.3760/cma.j.cn115610-20220607-00315
- VernacularTitle:积极参与国际高质量临床试验 提高中国结直肠外科临床研究水平
- Author:
Hongwei YAO
1
;
Zhengyang YANG
;
Jiale GAO
;
Yishan LIU
;
Jurriaan TUYNMAN
;
Jaap BONJER
;
Zhongtao ZHANG
Author Information
1. 首都医科大学附属北京友谊医院普通外科
- Keywords:
Rectal neoplasms;
Colorectal surgery;
Transanal total mesorectal excision;
Clinical trial;
International cooperation
- From:
Chinese Journal of Digestive Surgery
2022;21(6):749-752
- CountryChina
- Language:Chinese
-
Abstract:
The number of colorectal cancer patients in China ranks the top in the world, but there are few international guidelines for the diagnosis and treatment of colorectal cancer formulated by Chinese, nor high-level evidence-based medicine research of colorectal cancer from China. Transanal total mesorectal excision (taTME) is a new technology in the field of colorectal surgery in recent years. At present, clinical practice related to taTME has been carried out simul-taneously with clinical researches in the world. Based on the experience of participating in the top clinical trials in the field of international colorectal surgery, like the COLOR series prospective research, the authors introduce the organization and implementation of COLOR Ⅲ research in China. It is hoped that the COLOR series trials will become an example in the field of high-quality surgical clinical research, so as to improve the clinical research level of colorectal surgery in China.
